Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14503254 | 1.00 | CYP3A4 (0.46) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL1902163 | 1.00 | CYP3A4 (0.46) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL6683114 | 0.79 | PARP1 (0.48) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL6683109 | 0.79 | PARP1 (0.48) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL17470662 | 0.78 | ALDH1A1 (0.37) | CYP3A4KDM4ENFKB1MAOBALDH1A1 | |
| SCHEMBL19783142 | 0.78 | ALDH1A1 (0.42) | CYP3A4KDM4ENFKB1MAOBALDH1A1 | |
| SCHEMBL11926014 | 0.74 | ALDH1A1 (0.39) | CYP3A4KDM4ENFKB1MAOBALDH1A1 | |
| SCHEMBL8489384 | 0.74 | KDM4E (0.46) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL8489380 | 0.74 | KDM4E (0.46) | CYP3A4KDM4EHTTCYP2D6CYP2C9 | |
| SCHEMBL28903939 | 0.70 | LDHA (0.47) | CYP3A4KDM4ECYP2C9MAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8920812-B2 | Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS | TAKEDA VACCINES, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140186396-A1 | METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS | TAKEDA VACCINES, INC. (US) | 2014-07-03 | — | — | US | disclosed |
| US-20130028933-A1 | METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS | LIGOCYTE PHARMACEUTICALS, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| EP-2496609-A2 | CHIMERIC RSV-F POLYPEPTIDE AND LENTIVIRUS OR ALPHA-RETROVIRUS GAG-BASED VLPS | Ligocyte Pharmaceuticals, Inc. (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20120213817-A1 | CHIMERIC RSV-F POLYPEPTIDE AND LENTIVIRUS OR ALPHA-RETROVIRUS GAG-BASED VLPS | LIGOCYTE PHAMACEUTICALS, INC. | 2012-08-23 | — | — | US | disclosed |
| US-20120093855-A1 | RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF | LIGOCYTE PHARMACEUTICALS, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-20110262483-A1 | METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS | LIGOCYTE PHARMACEUTICALS, INC. | 2011-10-27 | — | — | US | disclosed |
| EP-2367844-A2 | RSV F VLPS AND METHODS OF MANUFACTURE AND USE THEREOF | Ligocyte Pharmaceuticals, Inc. (US) | 2011-09-28 | — | — | EP | disclosed |
| EP-2362901-A1 | IMPROVED METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS | Ligocyte Pharmaceuticals, Inc. (US) | 2011-09-07 | — | — | EP | disclosed |
| WO-2011056899-A2 | CHIMERIC RSV-F POLYPEPTIDE AND LENTIVIRUS OR ALPHA-RETROVIRUS GAG-BASED VLPS | LIGOCYTE PHARMACEUTICALS, INC. (US) | 2011-05-12 | — | — | WO | disclosed |
| EP-0497921-A4 | — | ISAACS STEPHEN T (US) | 1995-06-28 | — | — | EP | disclosed |
| WO-1995012973-A1 | DEVICE AND METHOD FOR PHOTOACTIVATION | STERITECH, INC. (US) | 1995-05-18 | — | — | WO | disclosed |
| WO-1994020090-A1 | DECONTAMINATING CLINICAL SAMPLES | STERITECH, INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994012515-A1 | METHODS FOR TREATMENT OF ENZYME PREPARATIONS | STERITECH, INC. (US) | 1994-06-09 | — | — | WO | disclosed |
| US-5221608-A | Adding a polymerase and an isopsoralen compound to a mixture of nucleic acid and amplification reagents, and exposing to ultraviolet radiation to form isopsoralen monoadduct which inhibits polymerase | STERITECH, INC. | 1993-06-22 | — | — | US | disclosed |
| US-5184020-A | For treating photoreactive compounds | STERITECH, INC. | 1993-02-02 | — | — | US | disclosed |
| US-5139940-A | Isopsoralen derives; complex with nucleic acids | STERITECH, INC. | 1992-08-18 | — | — | US | disclosed |
| EP-0497921-A1 | ACTIVATION COMPOUNDS AND METHODS FOR NUCLEIC ACID STERILIZATION | ISAACS, Stephen T. (US) | 1992-08-12 | — | — | EP | disclosed |
| WO-1992007957-A1 | METHODS AND COMPOSITIONS FOR MINIMIZING INHIBITION OF NUCLEIC ACID AMPLIFICATION | CIMINO GEORGE D (US) | 1992-05-14 | — | — | WO | disclosed |
| WO-1991006665-A1 | ACTIVATION COMPOUNDS AND METHODS FOR NUCLEIC ACID STERILIZATION | ISAACS STEPHEN T (US) | 1991-05-16 | — | — | WO | disclosed |